Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$12.14
-7.3%
$15.47
$5.11
$19.22
$335.45M1.06214,785 shs195,574 shs
CVRx, Inc. stock logo
CVRX
CVRx
$12.27
-5.5%
$13.72
$6.40
$19.24
$319.46M1.34286,417 shs162,308 shs
FONAR Co. stock logo
FONR
FONAR
$13.80
+1.9%
$14.82
$13.27
$20.18
$85.60M1.2716,405 shs4,442 shs
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
$34.06
-8.0%
$43.29
$20.88
$81.56
$326.87M1.33389,034 shs226,886 shs
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
0.00%+5.06%-3.39%-15.77%+102.95%
CVRx, Inc. stock logo
CVRX
CVRx
+3.59%+3.02%+5.10%-4.42%-24.53%
FONAR Co. stock logo
FONR
FONAR
-0.15%-2.66%-7.07%-10.33%-32.47%
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
+1.40%-6.42%-4.78%-32.18%+31.41%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
2.0545 of 5 stars
3.53.00.00.02.50.00.6
CVRx, Inc. stock logo
CVRX
CVRx
2.1871 of 5 stars
3.41.00.00.02.72.50.6
FONAR Co. stock logo
FONR
FONAR
1.4271 of 5 stars
0.03.00.00.02.80.81.9
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
3.4907 of 5 stars
3.54.00.00.03.22.51.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
3.00
Buy$25.00105.93% Upside
CVRx, Inc. stock logo
CVRX
CVRx
2.86
Moderate Buy$17.8345.34% Upside
FONAR Co. stock logo
FONR
FONAR
0.00
N/AN/AN/A
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
3.00
Buy$71.00108.46% Upside

Current Analyst Ratings Breakdown

Latest FONR, SMLR, CLPT, and CVRX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/1/2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$19.00 ➝ $25.00
2/5/2025
CVRx, Inc. stock logo
CVRX
CVRx
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$16.00 ➝ $20.00
2/5/2025
CVRx, Inc. stock logo
CVRX
CVRx
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$22.00 ➝ $23.00
1/28/2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$15.00 ➝ $20.00
1/24/2025
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$40.00 ➝ $71.00
1/21/2025
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$17.00 ➝ $30.00
1/17/2025
CVRx, Inc. stock logo
CVRX
CVRx
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$20.00 ➝ $22.00
1/14/2025
CVRx, Inc. stock logo
CVRX
CVRx
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform
(Data available from 4/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
$31.39M10.69N/AN/A$0.86 per share14.12
CVRx, Inc. stock logo
CVRX
CVRx
$51.29M6.23N/AN/A$2.73 per share4.49
FONAR Co. stock logo
FONR
FONAR
$101.57M0.84$2.89 per share4.78$25.62 per share0.54
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
$56.29M5.81$2.01 per share16.95$10.45 per share3.26
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$22.09M-$0.70N/AN/AN/A-59.64%-62.10%-38.39%5/6/2025 (Estimated)
CVRx, Inc. stock logo
CVRX
CVRx
-$59.97M-$2.69N/AN/AN/A-116.91%-93.06%-51.78%4/29/2025 (Estimated)
FONAR Co. stock logo
FONR
FONAR
$10.57M$1.1512.00N/A7.68%4.94%3.70%5/13/2025 (Estimated)
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
$20.58M$4.916.94N/A72.65%50.77%47.04%5/5/2025 (Estimated)

Latest FONR, SMLR, CLPT, and CVRX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/29/2025N/A
CVRx, Inc. stock logo
CVRX
CVRx
-$0.54N/AN/AN/A$14.68 millionN/A
2/26/2025Q4 2024
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
-$0.15-$0.20-$0.05-$0.20$8.23 million$7.77 million
2/19/2025Q2 2025
FONAR Co. stock logo
FONR
FONAR
N/A$0.29N/A$0.29N/A$24.95 million
2/18/2025Q4 2024
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
$0.20$3.41+$3.21$3.41N/A$12.41 million
2/4/2025Q4 2024
CVRx, Inc. stock logo
CVRX
CVRx
-$0.37-$0.43-$0.06-$0.43N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/AN/AN/AN/AN/A
CVRx, Inc. stock logo
CVRX
CVRx
N/AN/AN/AN/AN/A
FONAR Co. stock logo
FONR
FONAR
N/AN/AN/AN/AN/A
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
N/A
4.54
3.61
CVRx, Inc. stock logo
CVRX
CVRx
0.69
12.06
10.23
FONAR Co. stock logo
FONR
FONAR
N/A
11.24
9.45
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
N/A
3.14
3.09

Institutional Ownership

CompanyInstitutional Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
30.08%
CVRx, Inc. stock logo
CVRX
CVRx
75.27%
FONAR Co. stock logo
FONR
FONAR
50.64%
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
49.37%

Insider Ownership

CompanyInsider Ownership
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
6.11%
CVRx, Inc. stock logo
CVRX
CVRx
18.90%
FONAR Co. stock logo
FONR
FONAR
2.17%
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
30.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
ClearPoint Neuro, Inc. stock logo
CLPT
ClearPoint Neuro
11027.63 million25.90 millionOptionable
CVRx, Inc. stock logo
CVRX
CVRx
16026.04 million21.12 millionOptionable
FONAR Co. stock logo
FONR
FONAR
4806.20 million6.19 millionNot Optionable
Semler Scientific, Inc. stock logo
SMLR
Semler Scientific
1209.60 million6.47 millionNot Optionable

Recent News About These Companies

Semler Scientific discloses DOJ probe over QuantaFlo’s use
Semler Scientific reports Q4 EPS $3.41 vs. 55c last year

New MarketBeat Followers Over Time

Media Sentiment Over Time

ClearPoint Neuro stock logo

ClearPoint Neuro NASDAQ:CLPT

$12.14 -0.95 (-7.26%)
Closing price 04:00 PM Eastern
Extended Trading
$12.14 +0.00 (+0.04%)
As of 06:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

CVRx stock logo

CVRx NASDAQ:CVRX

$12.27 -0.71 (-5.47%)
Closing price 04:00 PM Eastern
Extended Trading
$12.28 +0.02 (+0.12%)
As of 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

FONAR stock logo

FONAR NASDAQ:FONR

$13.76 +0.22 (+1.59%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Semler Scientific stock logo

Semler Scientific NASDAQ:SMLR

$34.06 -2.97 (-8.02%)
Closing price 04:00 PM Eastern
Extended Trading
$34.15 +0.09 (+0.25%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.